Kidswell Bio Corporation (TYO:4584)
Japan · Delayed Price · Currency is JPY 160.00
-5.00 (-3.03%)
Sep 16, 2026, 3:30 PM JST
Kidswell Bio Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| 8,093 | 12,057 | 4,814 | 14,460 | 14,930 | 14,487 | |
Market Cap Growth | -34.16% | 150.47% | -66.71% | -3.15% | 3.06% | -17.22% |
Enterprise Value | 7,335 | 10,897 | 5,529 | 13,907 | 14,301 | 13,230 |
Last Close Price | 160.00 | 243.00 | 112.00 | 460.00 | 504.00 | 524.00 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Forward PE | 7.31 | 14.25 | 15.50 | - | - | - |
PS Ratio | 1.32 | 1.83 | 0.95 | 9.22 | 14.99 | 13.45 |
PB Ratio | 4.41 | 7.30 | 3.42 | 8.42 | 9.28 | 9.74 |
P/TBV Ratio | 4.41 | 7.30 | 3.42 | 8.44 | 9.29 | 9.74 |
P/FCF Ratio | - | - | 5.18 | - | - | - |
P/OCF Ratio | - | - | 5.14 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
EV/Sales Ratio | 1.20 | 1.65 | 1.09 | 8.86 | 14.36 | 12.28 |
EV/EBIT Ratio | - | - | 197.45 | - | - | - |
EV/FCF Ratio | - | - | 5.95 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Debt / Equity Ratio | 1.35 | 1.54 | 1.30 | 0.41 | 0.68 | 0.82 |
Debt / FCF Ratio | - | - | 1.98 | - | - | - |
Net Debt / Equity Ratio | -0.41 | -0.45 | -0.82 | -0.28 | -0.22 | -0.54 |
Net Debt / EBITDA Ratio | - | 5.37 | - | 0.53 | - | 0.70 |
Net Debt / FCF Ratio | - | 0.67 | -1.25 | 0.42 | 0.28 | 0.61 |
Asset Turnover | 0.97 | 1.01 | - | 0.42 | 0.27 | 0.32 |
Inventory Turnover | 6.83 | 5.51 | - | 0.77 | 0.34 | 4.92 |
Quick Ratio | 1.81 | 1.94 | 1.00 | 1.46 | 2.04 | 3.05 |
Current Ratio | 2.73 | 2.72 | 1.55 | 2.95 | 3.00 | 3.78 |
Return on Equity (ROE) | -19.21% | -26.98% | - | -32.17% | -64.66% | -346.87% |
Return on Assets (ROA) | -1.06% | -1.33% | - | -15.45% | -16.11% | -21.54% |
Return on Invested Capital (ROIC) | -10.85% | -24.01% | -1.09% | -74.17% | -100.62% | -165.78% |
Return on Capital Employed (ROCE) | -2.70% | -3.50% | 1.00% | -38.70% | -34.40% | -42.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Earnings Yield | -4.61% | -3.43% | -0.44% | -3.70% | -6.71% | -50.50% |
FCF Yield | -13.75% | -9.23% | 19.32% | -8.08% | -8.49% | -9.15% |
Buyback Yield / Dilution | -3.56% | -20.48% | -31.28% | -7.16% | -4.14% | -41.55% |